Spectral Diagnostics (EDTXF) 0.8000 $EDTXF
Spectral Announces Voting Results of Annual and Special Meeting
Marketwired - Wed May 13, 11:27AM CDT
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced that at the annual and special meeting (the "Meeting" of shareholders of the Corporation ("Shareholders" that was held yesterday, all six nominees for the board were elected, the voting results of which are as follows:
EDT.TO: 0.95 (-0.02)
Spectral Announces First Quarter 2015 Results
Marketwired - Wed May 13, 7:02AM CDT
Spectral Medical Inc., (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced its unaudited financial results for the first quarter ended March 31, 2015.
EDT.TO: 0.95 (-0.02)
Spectral Medical Provides Regulatory Update
Marketwired - Wed Apr 22, 7:03AM CDT
Spectral Medical Inc. ("Spectral" or the "Company" (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced that the United States Food and Drug Administration (FDA) has accepted the Company's plan, and related content, for a rolling Pre Market Approval (PMA) submission for its treatment for septic shock.
EDT.TO: 0.95 (-0.02)
Spectral Ranks Amongst Top 10 Game-Changing Health Technologies
Marketwired - Thu Apr 16, 11:59AM CDT
Spectral Medical Inc. ("Spectral" or the "Company" (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced the Company`s unique treatment for septic shock was included as a top 10 game-changing health technology by the Canadian Network for Environmental Scanning and Health (CNESH) and a panel of clinical experts.
EDT.TO: 0.95 (-0.02)
Spectral Announces Closing of CDN$6.1 Million Offering
Marketwired - Wed Apr 01, 7:47AM CDT
Spectral Medical Inc. ("Spectral" or the "Company" (TSX: EDT) (OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today completed its previously announced offering of 11,049,464 common shares ("Shares" at a price of CDN$0.553 per Share for net proceeds of CDN$6,110,353 (the "Offering".
EDT.TO: 0.95 (-0.02)
Spectral Reports Increase in Previously Announced Offering to CDN$6.1 Million
Marketwired - Mon Mar 30, 7:01AM CDT
Spectral Medical Inc. ("Spectral" or the "Company" (TSX: EDT) (OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced that, in connection with the previously announced offering to Toray Industries, Inc. ("Toray" of 9,041,592 common shares ("Shares" at a price of CDN$0.553 per Share (the "Subscription Price" pursuant to the exercise of the Company's call right (the "Call Right", Birch Hill Equity Partners IV, LP, Birch Hill Equity Partners (US) IV, LP, and Birch Hill Equity Partners (Entrepreneurs) IV, LP (collectively, the "Birch Hill LPs" have exercised their anti-dilution rights to acquire 2,007,872 Shares at the Subscription Price, for net proceeds of CDN$1,110,353. As a result, the Company will issue an aggregate of 11,049,464 Shares under the offering for net proceeds of CDN$6,110,353 (the "Offering".
EDT.TO: 0.95 (-0.02)
Spectral Announces Fourth Quarter and Fiscal 2014 Results
Marketwired - Wed Mar 25, 7:03AM CDT
Spectral Medical Inc., (TSX: EDT)(OTCQX: EDTXQ), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its financial results for the fourth quarter and for the year ended December 31, 2014.
EDT.TO: 0.95 (-0.02)
Spectral Announces $5 Million Offering of Common Shares Pursuant to Exercise of Call Right
Marketwired - Mon Mar 16, 7:03AM CDT
Spectral Medical Inc. ("Spectral" or the "Company" (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, announced today that on March 14, 2015 it exercised the call right (the "Call Right" previously granted to it by Toray Industries, Inc. ("Toray" for Toray to purchase 9,041,592 common shares ("Shares" in the capital of the Company (the "Offering" at a subscription price of CDN$0.553 per Share, for net proceeds of CDN$5 million. The subscription price for the Shares was determined pursuant to the terms of the Call Right and is based on the volume weighted average price of the Shares on the Toronto Stock Exchange for the twenty trading day period ended on March 13, 2015, being the day prior to the date the Company exercised the Call Right.
EDT.TO: 0.95 (-0.02)
Spectral Announces Results of DSMB Meeting
Marketwired - Tue Mar 10, 7:03AM CDT
Spectral Medical Inc. ("Spectral" or the "Company" (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced the results of the Data Safety and Monitoring Board (DSMB) recent meeting and its recommendations to Spectral. The DSMB is an independent body of experts in the fields of clinical medicine, biostatistics and trial methodology, which functions via a charter approved by the U.S. Food and Drug Administration (FDA) to review the accumulated data of Spectral's trial and to provide recommendations to the Company on a regular basis.
EDT.TO: 0.95 (-0.02)
Spectral Provides Update to Shareholders
Marketwired - Thu Feb 19, 7:03AM CST
Spectral Medical Inc. ("Spectral" or the "Company" (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first therapy for patients with septic shock guided by a diagnostic, is pleased to provide the Company's shareholders with an updated investor presentation which can be downloaded from the Spectral website at www.spectraldx.com or by simply clicking on the link below:
EDT.TO: 0.95 (-0.02)
Spectral Announces Voting Results of Annual and Special Meeting
Marketwired - Wed May 13, 11:27AM CDT
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced that at the annual and special meeting (the "Meeting" of shareholders of the Corporation ("Shareholders" that was held yesterday, all six nominees for the board were elected, the voting results of which are as follows: EDT.TO: 0.95 (-0.02)
Spectral Announces First Quarter 2015 Results
Marketwired - Wed May 13, 7:02AM CDT
Spectral Medical Inc., (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced its unaudited financial results for the first quarter ended March 31, 2015.
EDT.TO: 0.95 (-0.02)
Spectral Medical Provides Regulatory Update
Marketwired - Wed Apr 22, 7:03AM CDT
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced that the United States Food and Drug Administration (FDA) has accepted the Company's plan, and related content, for a rolling Pre Market Approval (PMA) submission for its treatment for septic shock. EDT.TO: 0.95 (-0.02)
Spectral Ranks Amongst Top 10 Game-Changing Health Technologies
Marketwired - Thu Apr 16, 11:59AM CDT
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced the Company`s unique treatment for septic shock was included as a top 10 game-changing health technology by the Canadian Network for Environmental Scanning and Health (CNESH) and a panel of clinical experts. EDT.TO: 0.95 (-0.02)
Spectral Announces Closing of CDN$6.1 Million Offering
Marketwired - Wed Apr 01, 7:47AM CDT
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT) (OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today completed its previously announced offering of 11,049,464 common shares ("Shares" at a price of CDN$0.553 per Share for net proceeds of CDN$6,110,353 (the "Offering". EDT.TO: 0.95 (-0.02)
Spectral Reports Increase in Previously Announced Offering to CDN$6.1 Million
Marketwired - Mon Mar 30, 7:01AM CDT
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT) (OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced that, in connection with the previously announced offering to Toray Industries, Inc. ("Toray" of 9,041,592 common shares ("Shares" at a price of CDN$0.553 per Share (the "Subscription Price" pursuant to the exercise of the Company's call right (the "Call Right", Birch Hill Equity Partners IV, LP, Birch Hill Equity Partners (US) IV, LP, and Birch Hill Equity Partners (Entrepreneurs) IV, LP (collectively, the "Birch Hill LPs" have exercised their anti-dilution rights to acquire 2,007,872 Shares at the Subscription Price, for net proceeds of CDN$1,110,353. As a result, the Company will issue an aggregate of 11,049,464 Shares under the offering for net proceeds of CDN$6,110,353 (the "Offering". EDT.TO: 0.95 (-0.02)
Spectral Announces Fourth Quarter and Fiscal 2014 Results
Marketwired - Wed Mar 25, 7:03AM CDT
Spectral Medical Inc., (TSX: EDT)(OTCQX: EDTXQ), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its financial results for the fourth quarter and for the year ended December 31, 2014.
EDT.TO: 0.95 (-0.02)
Spectral Announces $5 Million Offering of Common Shares Pursuant to Exercise of Call Right
Marketwired - Mon Mar 16, 7:03AM CDT
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, announced today that on March 14, 2015 it exercised the call right (the "Call Right" previously granted to it by Toray Industries, Inc. ("Toray" for Toray to purchase 9,041,592 common shares ("Shares" in the capital of the Company (the "Offering" at a subscription price of CDN$0.553 per Share, for net proceeds of CDN$5 million. The subscription price for the Shares was determined pursuant to the terms of the Call Right and is based on the volume weighted average price of the Shares on the Toronto Stock Exchange for the twenty trading day period ended on March 13, 2015, being the day prior to the date the Company exercised the Call Right. EDT.TO: 0.95 (-0.02)
Spectral Announces Results of DSMB Meeting
Marketwired - Tue Mar 10, 7:03AM CDT
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced the results of the Data Safety and Monitoring Board (DSMB) recent meeting and its recommendations to Spectral. The DSMB is an independent body of experts in the fields of clinical medicine, biostatistics and trial methodology, which functions via a charter approved by the U.S. Food and Drug Administration (FDA) to review the accumulated data of Spectral's trial and to provide recommendations to the Company on a regular basis. EDT.TO: 0.95 (-0.02)
Spectral Provides Update to Shareholders
Marketwired - Thu Feb 19, 7:03AM CST
Spectral Medical Inc. ("Spectral" or the "Company"
(TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first therapy for patients with septic shock guided by a diagnostic, is pleased to provide the Company's shareholders with an updated investor presentation which can be downloaded from the Spectral website at www.spectraldx.com or by simply clicking on the link below: EDT.TO: 0.95 (-0.02)
